Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Blood
Reexamination Certificate
2005-09-13
2005-09-13
Naff, David M. (Department: 1651)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Blood
C210S645000, C424S093700, C435S002000, C435S180000, C435S269000, C435S395000, C435S289100
Reexamination Certificate
active
06942879
ABSTRACT:
A novel cell seeded hollow fiber bioreactor is described as a potential bioartificial kidney. Endothelial cells along with pericyte, vascular smooth muscle, and/or mesangial cells or any mesenchymally derived support cells are seeded along a hollow fiber in a perfused bioreactor to reproduce the ultrafiltration function and transport function of the kidney. Maintenance of tissue specific function and ultrastructure suggest that this bioreactor provides an economical device for treating renal failure.
REFERENCES:
patent: 3734851 (1973-05-01), Matsumura
patent: 4242460 (1980-12-01), Chick et al.
patent: 4354933 (1982-10-01), Lester
patent: 4973493 (1990-11-01), Guire
patent: 5002582 (1991-03-01), Guire et al.
patent: 5360790 (1994-11-01), Humes
patent: 5414075 (1995-05-01), Swan et al.
patent: 5429938 (1995-07-01), Humes
patent: 5437994 (1995-08-01), Emerson et al.
patent: 5459069 (1995-10-01), Palsson et al.
patent: 5499976 (1996-03-01), Dalton
patent: 5516680 (1996-05-01), Naughton et al.
patent: 5549674 (1996-08-01), Humes et al.
patent: 5550050 (1996-08-01), Holland et al.
patent: 5580697 (1996-12-01), Keana et al.
patent: 5605822 (1997-02-01), Emerson et al.
patent: 5639275 (1997-06-01), Baetge et al.
patent: 5653975 (1997-08-01), Baetge et al.
patent: 5656481 (1997-08-01), Baetge et al.
patent: 5661133 (1997-08-01), Leiden et al.
patent: 5676943 (1997-10-01), Baetge et al.
patent: 5686289 (1997-11-01), Humes et al.
patent: 5733727 (1998-03-01), Field
patent: 5763266 (1998-06-01), Palsson et al.
patent: 5773286 (1998-06-01), Dionne et al.
patent: 5795790 (1998-08-01), Schinstine et al.
patent: 5833978 (1998-11-01), Tremblay
patent: 5843781 (1998-12-01), Ballermann et al.
patent: 5858653 (1999-01-01), Duran et al.
patent: 5906817 (1999-05-01), Moullier et al.
patent: 5919449 (1999-07-01), Dinsmore
patent: 6060270 (2000-05-01), Humes
patent: 6110209 (2000-08-01), Stone
patent: 6150164 (2000-11-01), Humes
patent: 6156304 (2000-12-01), Glorioso et al.
patent: 6410320 (2002-06-01), Humes
patent: 6653131 (2003-11-01), Humes
patent: 2001/0041363 (2001-11-01), Humes
patent: 1 479 002 (1974-06-01), None
patent: WO 89/01967 (1989-03-01), None
patent: WO 91/00119 (1991-01-01), None
patent: WO 92/07615 (1992-05-01), None
patent: WO 93/17696 (1993-09-01), None
Voldman, et al., “Microfabrication in Biology and Medicine”, Annu. Rev. Biomed. Eng.:1(1), pp. 401-425.
B.R. Olsen, “Matrix Molecules and Their Ligands”, Principles of Tissue Engineering, pp. 48-65, 1997.
R. Calafiore, et al., “Coherent Microcapsules for Pancreatic Islet Transplantation: A New Approach for Bioartificial Pancreas”, Transplantation Proceedings, vol. 28, No. 2, (Apr.), 1996: pp. 812-813.
H. Hayashi, et al., “Long Survival of Xenografted Bioartificial Pancreas with a Mesh-Reinforced Polyvinyl Alcohol Hydrogel Bag Employing a B-Cell Line (MIN6)”, Transplantation Proceedings, vol. 28, No. 3 (Jun.), 1996: pp. 1428-1429.
N. Trivedi, et al., “Improved Vascularization of Planar Membrane Diffusion Devices Following Continuous Infusion of Vascular Endothelial Growth Factor”, Cell Transplantation, vol. 9, 2000, pp. 115-124.
B. Busse, et al., “Bioreactors for Hybrid Liver Support: Historical Aspects an Novel Designs”, Annals of The New York Academy of Sciences, vol. 875, 1999, pp. 326-339.
A. Trifillis, et al., “Isolation, Culture and Characterization of Human Renal Tubular Cells”, The journal of Urology, vol. 133, 1985, pp. 324-329..
C. Detrisac, et al., “Tissue Culture of Human Kidney Epithelial Cells of Proximal Tubule Origin”, Kidney International, vol. 25, 1984, pp. 383-390.
K. Naruse, et al., “Efficacy of a Bioreactor Filled with Porcine Hepatocytes Immobilized on Nonwoven Fabric for Ex Vivo Direct Hemoperfusion Treatment of Liver Failure in Pigs”, International Society for Artificial Organs, 22(12): pp. 1031-1037, Blackwell Science, Inc., 1998.
C. Delaunay, et al., “Glucose-Insulin Kinetics of a Bioartificial Pancreas Made of an AN69 Hydrogel Hollow Fiber Containing Porcine Islets and Implanted in Diabetic Mice”, International Society for Artificial Organs, 22(4): pp. 291-299, Blackwell Science, Inc., 1998.
V. Dixit, et al., The Bioartificial Liver: State-of-the-Art, Eur. J. Surg., 1998: Suppl. 582: pp. 71-76.
H. Ohgawara, et al., “Membrane Immunoisolation of a Diffusion Chamber for a Bioartificial Pancreas”, International Society for Artificial Organs, 22(9), 1998, pp. 788-794.
S. K. Hunter, et al., “Encapsulated β-islet cells as a bioartificial pancreas to treat insulin-dependent diabetes during pregancy”, Am. J. Obstet. Gynecol., vol. 177, No. 4, pp. 746-752.
M. R. Pillarella, “Theoretical Analysis of the Effect of Convective Flow on Solute Transport and Insulin Release in a Hollow Fiber Bioartificial Pancreas”, Journal of Biomechanical Engineering, May 1990, vol. 112, pp. 220-228.
J. A. Thompson, et al., “Site-Directed Neovessel Formation in Vivo”, Science Reports, Sep. 9, 1988, pp. 1349-1352.
S. E. Feinberg, et al., “Role of Biomimetics in Reconstruction of the Temporomandibular Joint”, Oral and Maxillofacial Surgery Clinics of North America, vol. 12, No. 1, Feb. 2000, pp. 149-160.
N. E. Mukundan, et al., “Oxygen Consumption Rates of Free and Alginate-entrapped βTC3 Mouse Insulinoma Cells”, Biochemical and Biophysical Research Communications, vol. 210, No. 1, May 5, 1995, pp. 113-118.
Y. Tanaka, et al., “Generation of an autologous tissue (matrix) flap by combining and arteriovenous shunt loop with artificial skin in rats: preliminary report”, British Journal of Plastic Surgery, (2000), 53, pp. 51-57.
R. Mian, et al., “Formation of New Tissue from an Arteriovenous Loop in the Absence of Added Extracellular Matrix”, Tissue Engineering, vol. 6, No. 6, 2000, pp. 595-603.
G. Ahrendt, et al., “Angiogenic Growth Factors: A Review for Tissue Engineering”, Tissue Engineering, vol. 4, No. 2, 1998, pp. 117-131.
C. K. Colton, “Engineering challenges in cell-encapsulation technology”, Tibtech, May 1996, vol. 14, pp. 158-162.
C. K. Colton, “Bioengineering in Development of the Hybrid Artificial Pancreas”, Journal of Biomechanical Engineering, vol. 113, May 1991, pp. 152-170.
R. P. Lanza, et al., “Transplantation of islet Allografts Using a Diffusion-Based Biohybrid Artificial Pancreas: Long-Term Studies in Diabetic, Pancreatectomized Dogs”, Transplantation Proceedings, vol. 25, No. 1, Feb., 1993: pp. 978-980.
C. A. Ramirez, et al., “In Vitro Perfusion of Hybride Artificial Pancreas Devices at Low Flow Rates”, ASAIO Journal 1992, pp. M443-M449.
S. Esser, et al., “Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro”, The Journal of Cell Biology, vol. 140, No. 4, Feb. 23, 1998, pp. 947-959.
Y.S. Chang, et al., “Effect of Vascular Endothelial Growth Factor on Cultured Endothelial Cell Monolayer Transport Properties”, Microvascular Research 59, pp. 265-277, 2000.
A. Hempel, et al., “Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability”, The American Physilogical Society, pp. H1818-H1825.
T. A. Desi, et al., Microfabricated Immunoisolating Biocapsules', Biotechnology and Bioengineering, vol. 57, No. 1, Jan. 5, 1998, pp. 118-120.
T. Murohara, et al., “Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization”, The Journal of Clinical Investigation, Jun. 2000, vol. 105, No. 11, pp. 1527-1536.
P. Carmeliet, et al., “Mechanism of angiogenesis and arteriogenesis”, Nature Medicine, vol. 6, No. 3, Mar. 2000, pp. 389-395.
R. B. Vernon, et al., “A Novel, Quantitative Model for Study of Endothelial Cell Migration and Sprout Formation within Three-Dimensional Collagen Matrices”, Microvascular Research 57, pp. 118-133, 1999.
V.
LandOfFree
Bioartificial filtration device for filtering blood to mimic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioartificial filtration device for filtering blood to mimic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioartificial filtration device for filtering blood to mimic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3429490